1. Jiang, Shu-Heng, Zhu, Li-Li, Zhang, Man, Hou, Shangwei, Zhang, Zhi-Gang. 2019. GABRP regulates chemokine signalling, macrophage recruitment and tumour progression in pancreatic cancer through tuning KCNN4-mediated Ca2+ signalling in a GABA-independent manner. In Gut, 68, 1994-2006. doi:10.1136/gutjnl-2018-317479. https://pubmed.ncbi.nlm.nih.gov/30826748/
2. Chen, Chen, Wu, Binfeng, Wang, Mingge, Huang, Zhaohui, Shi, Jin-Song. 2022. GABRP promotes CD44s-mediated gemcitabine resistance in pancreatic cancer. In PeerJ, 10, e12728. doi:10.7717/peerj.12728. https://pubmed.ncbi.nlm.nih.gov/35846884/
3. Kim, Hun-Soo, Jin, Eun-Heui, Mo, Ji-Su, Lee, Shin-Seok, Chae, Soo-Cheon. 2015. The Association of the GABRP Polymorphisms with Systemic Lupus Erythematosus. In Journal of immunology research, 2015, 602154. doi:10.1155/2015/602154. https://pubmed.ncbi.nlm.nih.gov/26634217/
4. Zafrakas, Menelaos, Chorovicer, Marina, Klaman, Irima, Knüchel, Ruth, Dahl, Edgar. . Systematic characterisation of GABRP expression in sporadic breast cancer and normal breast tissue. In International journal of cancer, 118, 1453-9. doi:. https://pubmed.ncbi.nlm.nih.gov/16187283/
5. Yang, Yihui, Ren, Liwen, Li, Sha, Wang, Jinhua, Du, Guanhua. . GABRP is a potential prognostic biomarker and correlated with immune infiltration and tumor microenvironment in pancreatic cancer. In Translational cancer research, 11, 649-668. doi:10.21037/tcr-21-2021. https://pubmed.ncbi.nlm.nih.gov/35571651/